index - Plateforme d’immortalisation MyoLine – CRM Accéder directement au contenu

Dernières publications

Chiffres clés

47 Publications with fulltext

Open Access

86 %

Mots clés

FoxO Conjugation CLS Mitochondrial ROS KLF15 FSHD DNM2 Mechanisms of disease Adhesion Immortalized dystrophic canine myoblast 3D co-culture Flavonoid Skeletal muscle Lamin A/C nuclei DM1 myoblasts Autophagy Human Dominant centronuclear myopathy Neuromuscular junction Lamina-associated domain Mechano-transduction Migration DMD Fear response Fibroblast Gel electrophoresis Endocytosis Gene network analysis Becker muscular dystrophy Microarray CFTR correctors Motor neuron Cell biology Allele-specific silencing therapy Adeno-associated viral vector Human artificial chromosomes Glucocorticoid-induced muscle atrophy CRISPR/Cas9 Expanded repeats BMD Exondys 51 Computer software CMS Clinical trial candidate screening Eteplirsen Antisense oligonucleotide RNA interference CXCL12 ITSN1 Actin Gene therapy Mdx HDMD/Dmd-null mice Exon skipping CTG⋅CAGn repeat Duchenne muscular dystrophy Insulin Machine learning Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Coculture Myotonic dystrophy Acetylcholine receptor subunit epsilon MSCs Drisapersen Dystrophin Mdx52 mice Alternative splicing MT RNA/DNA Editing Gut microbiota Lymphotoxin-β-receptor Canine X-linked muscular dystrophy in Japan CXMD J LRP4 Dynamin 2 Centronuclear myopathy Folding-defective proteins Laminographie BAF Autophagosome Differentiation Muscle Chromatin Cell-penetrating peptide Bile acid Myogenesis Human muscle stem/progenitor cells CXCR4 Emerin Allele-specific silencing Fibrosis Myotube CDNA synthesis Antisense morpholino Exon-skipping Atrial cardiac defects Developmental biology DsDNA break repair Glucose Immortalisation LTβR ICU-acquired weakness